Metraipolis › archive › dc_7d7d481d2beb

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2 — Europe PMC PMID:41162224

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41162224
DOI: 10.1111/cea.70162
License (as archived): solo-consultazione
Archived: 2026-11-08T23:33:58.527Z
SHA-256 of the archived text: baca570e9677ddacc4faf5cfebeaf0b3ebea3ee446766091fac33233b539f3cf
Stable URL of this page: https://metraipolis.com/documento/dc_7d7d481d2beb

How to cite

Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2 — Europe PMC PMID:41162224 — Europe PMC (en), https://europepmc.org/article/MED/41162224 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7d7d481d2beb (Metraipolis archive dc_7d7d481d2beb, sha256 baca570e9677ddacc4faf5cfebeaf0b3ebea3ee446766091fac33233b539f3cf)

BibTeX

@misc{dc7d7d481d2beb,
  title = {Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2 — Europe PMC PMID:41162224},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41162224},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7d7d481d2beb; sha256 baca570e9677ddacc4faf5cfebeaf0b3ebea3ee446766091fac33233b539f3cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41162224. Agents can read the archived copy with the MCP tool read_document.